Kontour (Xi'an) Medical Technology Co., Ltd. (SHA:688314)

SHA:688314 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	88.4	75.51	75.69	81.63
Depreciation & Amortization	13.23	12.31	11.82	10.63
Other Amortization	3.7	3.12	2.66	1.43
Loss (Gain) From Sale of Assets	-0.46	0.04	0	-0.02
Asset Writedown & Restructuring Costs	1.89	0.03	0.04	0.35
Loss (Gain) From Sale of Investments	12.59	1.86	-3.45	-2.16
Provision & Write-off of Bad Debts	-0.34	-0	0.2	-0.04
Other Operating Activities	6.5	9.65	5.55	5.37
Change in Accounts Receivable	2.91	-0.1	-4.52	-3.75
Change in Inventory	6.78	-5.24	-6.61	-5.49
Change in Accounts Payable	6.47	-11.31	10.78	16.04
Operating Cash Flow	140.25	85.22	91.98	103.29
Operating Cash Flow Growth	64.57%	-7.34%	-10.95%	78.61%
Capital Expenditures	-47.4	-14.22	-18.2	-55.24
Sale of Property, Plant & Equipment	0.66	0.01	-	0.02
Cash Acquisitions	-10.78	-	-	-
Investment in Securities	-30.64	-13.82	-10.07	2.48
Other Investing Activities	-3.2	-	-	-
Investing Cash Flow	-91.36	-28.04	-28.27	-52.74
Long-Term Debt Issued	-	-	15.01	4
Long-Term Debt Repaid	-2.62	-2.47	-2.15	-3.33
Net Debt Issued (Repaid)	-2.62	-2.47	12.86	0.67
Issuance of Common Stock	-	-	-	224.6
Common Dividends Paid	-42.7	-31.82	-36.9	-30.65
Other Financing Activities	-0.63	2.5	-17.4	-12.13
Financing Cash Flow	-45.95	-31.79	-41.43	182.49
Foreign Exchange Rate Adjustments	-0.33	0.49	1.63	-0.51
Net Cash Flow	2.62	25.88	23.91	232.53
Free Cash Flow	92.86	71	73.78	48.05
Free Cash Flow Growth	30.78%	-3.76%	53.56%	-
Free Cash Flow Margin	28.84%	25.82%	30.75%	22.61%
Free Cash Flow Per Share	1.15	0.87	0.91	0.66
Cash Income Tax Paid	53.96	55.05	33.71	26.83
Levered Free Cash Flow	60.45	47.96	47.09	21.99
Unlevered Free Cash Flow	61.81	49.15	47.86	22.45
Change in Working Capital	14.75	-17.29	-0.54	6.12

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.